Follow Us:Follow Us on Twitter Like Us on Facebook Follow Us on Google+ Watch videos on our Youtube channel
Pancreatic and Biliary Disease Research and Outcomes
Cedars-Sinai Pancreatic and Biliary (PB) Disease Program is a pacesetter within the field of interventional endoscopy. The program conducts research to find new treatments and management strategies for pancreatitis and other gastroenterology problems.
Through careful analysis of thousands of individual cases, the PB physicians and their research team are committed to advances in patient care and GI technology: Investigational studies have not only strengthened the use of new endoscopic devices but have set the stage for new imaging, stenting, and biopsy techniques.
Clinical findings have helped to improve the diagnosis and treatment of complex cases involving chronic pancreatitis, biliary obstructions, and intestinal lesions.
Some of our program’s research and clinical innovations include:
- Pioneering work in wireless capsule endoscopy of the small intestine – Under the leadership of Dr. Simon K. Lo, the PB team performed the first clinical case in the world, leading a multi-center comparative study between different capsule platforms.
- Collaboration with international centers to perform confocal laser endomicroscopy to visualize worrisome areas at the cellular level, potentially targeting dysplastic or early cancers.
- Collaboration with U.S. institutions to introduce the use of double-balloon enteroscopy.
- Novel approaches in detecting pancreatic and small bowel metastatic carcinoid tumors with unknown primary sites.
- Performance of ERCP in patients who have undergone Roux-en-y gastric bypass surgery.
Data from the Pancreatic and Biliary Disease research program has been presented in various journals and scientific meetings.
Patients with pancreatitis or other GI endoscopic problems may have an opportunity to participate in various clinical trials that are being conducted by the PB program. The ability to participate in such research depends on the eligibility requirements for the study, the patient's condition, and the stage of the trial.
For additional information, contact:
Special Projects and Research Coordinator
Phone: (310) 248-6618